China, Aug. 31 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A clinical study of transarterial infusion of liposome irinotecan and 5-FU plus intravenous leucovorin as second-line treatment for colorectal cancer liver metastases'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130991

Registration Time: 2026/08/27

Type: Interventional study

Primary Sponsor: Second Affiliated Hospital of Guangzhou Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=340181

Published by HT Digital Content Services with permission from Health Daily Digest....